EASD 2019: Insulin Degludec Is Linked to Lower Risk of Hypoglycemia Than Insulin Glargine U300
Though the primary endpoint was not confirmed, other secondary, exploratory hypoglycemia outcomes trended toward insulin degludec.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.